Effect of sodium-glucose Co-transporter 2 inhibitors on MCP-1 and uromodulin levels in patients with type 2 diabetes mellitus

Effect of sodium-glucose Co-transporter 2 inhibitors on MCP-1 and uromodulin levels in patients with type 2 diabetes mellitus

Background and aim: A class of anti-diabetic medications, namely Sodium Glucose Co-Transporter-2 (SGLT2) inhibitors, has shown their potential effects beyond glucose tolerance in Type 2 Diabetes Mellitus (T2DM) patients. These inhibitors may affect inflammatory indicators, including monocyte chemoat...

Full description

Saved in:
Bibliographic Details
Main Authors: Mani Pathak, Haya Majid, Parvej Khan, Md Masoom, Rizwana Parveen, Prem Kapur, Sunil Kohli, Nidhi
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Clinical Epidemiology and Global Health
Subjects:
Type 2 diabetes mellitus
Renal dysfunction
SGLT2 inhibitors
Inflammatory markers
Serum
Online Access:http://www.sciencedirect.com/science/article/pii/S2213398424003853
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items